Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
Ready to explore the untapped potential of these groundbreaking treatments
Research on similar GLP-1 peptides shows potency loss of 10-15% within the first month post-expiration, and potentially 30% or more within three months
Numerous clinical studies suggest that tirzepatide may lead to greater weight loss compared to semaglutide
Frequently Asked Questions (FAQs) about ReadyRx - GLP-1 1
In the ATTAIN-1 phase 3 clinical trial, participants on the highest dose who remained on treatment lost an average of about 12.4 percent of their body weight approximately 27.3 pounds over 72 weeks, compared to less than 1 percent for those on placebo
US$ 24.13
US$ 22.28
US$ 22.80
US$ 25.91
US$ 23.04
US$ 28.65
US$ 26.37
US$ 23.15
US$ 29.22
US$ 22.82
